![Peter Slover](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Slover
Directeur Financier/CFO chez
CONTINEUM THERAPEUTICS, INC.
Fortune : 45 084 $ au 31/05/2026
Profil
Peter T.
Slover is Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. since 2020.
Formerly, Mr. Slover was Chief Financial & Accounting Officer at Sophiris Bio, Inc. from 2013 to 2020.
From 2009 to 2010, served as Chief Financial Officer, CAO & SVP-Operations at Anadys Pharmaceuticals, Inc. Worked as an Auditor at KPMG LLP from 1997 to 2004.
Completed undergraduate education at Shippensburg University of Pennsylvania in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 3 342 ( 0,01 % ) | 45 084 $ | 31/05/2026 |
Postes actifs de Peter Slover
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur Financier/CFO | 01/09/2020 |
Anciens postes connus de Peter Slover
| Sociétés | Poste | Fin |
|---|---|---|
| SOPHIRIS BIO | Directeur Financier/CFO | 01/05/2020 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Directeur Financier/CFO | - |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2004 |
Formation de Peter Slover
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
 Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
